 |
|
Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast Cancer
Jeffrey N. Weitzel, MD;
Veronica I. Lagos, MS;
Carey A. Cullinane, MD;
Patricia J. Gambol, MS;
Julie O. Culver, MS;
Kathleen R. Blazer, MS;
Melanie R. Palomares, MD;
Katrina J. Lowstuter, MS;
Deborah J. MacDonald, PhD
JAMA. 2007;297:2587-2595.
Context An autosomal dominant pattern of hereditary breast cancer may be masked by small family size or transmission through males given sex-limited expression.
Objective To determine if BRCA gene mutations are more prevalent among single cases of early onset breast cancer in families with limited vs adequate family structure than would be predicted by currently available probability models.
Design, Setting, and Participants A total of 1543 women seen at US high-risk clinics for genetic cancer risk assessment and BRCA gene testing were enrolled in a prospective registry study between April 1997 and February 2007. Three hundred six of these women had breast cancer before age 50 years and no first- or second-degree relatives with breast or ovarian cancers.
Main Outcome Measure The main outcome measure was whether family structure, assessed from multigenerational pedigrees, predicts BRCA gene mutation status. Limited family structure was defined as fewer than 2 first- or second-degree female relatives surviving beyond age 45 years in either lineage. Family structure effect and mutation probability by the Couch, Myriad, and BRCAPRO models were assessed with stepwise multiple logistic regression. Model sensitivity and specificity were determined and receiver operating characteristic curves were generated.
Results Family structure was limited in 153 cases (50%). BRCA gene mutations were detected in 13.7% of participants with limited vs 5.2% with adequate family structure. Family structure was a significant predictor of mutation status (odds ratio, 2.8; 95% confidence interval, 1.19-6.73; P = .02). Although none of the models performed well, receiver operating characteristic analysis indicated that modification of BRCAPRO output by a corrective probability index accounting for family structure was the most accurate BRCA gene mutation status predictor (area under the curve, 0.72; 95% confidence interval, 0.63-0.81; P<.001) for single cases of breast cancer.
Conclusions Family structure can affect the accuracy of mutation probability models. Genetic testing guidelines may need to be more inclusive for single cases of breast cancer when the family structure is limited and probability models need to be recreated using limited family history as an actual variable.
Author Affiliations: Departments of Clinical Cancer Genetics (Drs Weitzel, Cullinane, Palomares, and MacDonald and Mss Lagos, Gambol, Culver, Blazer, and Lowstuter) and General Oncologic Surgery, City of Hope, Duarte, Calif (Dr Cullinane). Dr Cullinane is now with Long Beach Memorial Medical Center, Long Beach, Calif, and Ms Gambol is now with Saddleback Memorial Medical Center, Laguna Hills, Calif.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Limited Family Structure and Breast Cancer Risk
Edwin S. Iversen, Jr, Hormuzd A. Katki, Sining Chen, Donald A. Berry, and Giovanni Parmigiani
JAMA. 2007;298(17):2007.
EXTRACT
| FULL TEXT
Limited Family Structure and Breast Cancer Risk—Reply
Jeffrey N. Weitzel, Veronica I. Lagos, and Deborah J. MacDonald
JAMA. 2007;298(17):2007-2008.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Modeling Genetic Risk of Breast Cancer
Noah D. Kauff and Kenneth Offit
JAMA. 2007;297(23):2637-2639.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant
Hall et al.
Ann Oncol 2009;20:1517-1521.
ABSTRACT
| FULL TEXT
Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States
Huo et al.
JCO 2009;27:1184-1190.
ABSTRACT
| FULL TEXT
Clinical Cancer Genetics Remains a Specialized Area: How Do I Get There From Here?
Geier et al.
Am Soc Clin Oncol Ed Book 2009;2009:644-651.
ABSTRACT
| FULL TEXT
Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutaion carriers
James et al.
J. Med. Genet. 2008;45:765-766.
FULL TEXT
Performance of BRCA1/2 Mutation Prediction Models in Asian Americans
Kurian et al.
JCO 2008;26:4752-4758.
ABSTRACT
| FULL TEXT
Mammographically Determined Breast Density and Cancer Risk
Hall and B. Kopans, MD
Radiology 2008;248:1083-1084.
FULL TEXT
The Rise and Impending Decline of Screening Mammography
Hall
Radiology 2008;247:597-601.
FULL TEXT
How Should Women With Early-Onset Endometrial Cancer Be Evaluated for Lynch Syndrome?
Kauff
JCO 2007;25:5143-5146.
FULL TEXT
Limited Family Structure and Breast Cancer Risk
Iversen et al.
JAMA 2007;298:2007-2007.
FULL TEXT
Cancer Risk Models: Translating Family History into Clinical Management
Domchek and Antoniou
ANN INTERN MED 2007;147:515-517.
FULL TEXT
Limited Family Tree Affects Breast Cancer Risk Assessment
JWatch Women's Health 2007;2007:4-4.
FULL TEXT
Defining BRCA Mutation Status in Women with Limited Family Structures
JWatch Oncology and Hematology 2007;2007:5-5.
FULL TEXT
Modeling Genetic Risk of Breast Cancer
Kauff and Offit
JAMA 2007;297:2637-2639.
FULL TEXT
|
